Immunogenicity and safety of a nine-valent human papillomavirus vaccine in women 27-45 years of age compared to women 16-26 years of age: An open-label phase 3 study.
Elmar A Joura, Angels Ulied, Corinne Vandermeulen, Milagrosa Rua Figueroa, Ilkka Seppä, Juan José Hernandez Aguado, Anitta Ahonen, Olaf Reich, Miia Virta, Antonino Perino, Merce Peris Tuser, Klaus Peters, Massimo Origoni, Francesco Raspagliesi, Wiebren A A Tjalma, Philippe Tummers, Linn Woelber, Pekka Nieminen, Pierre van Damme, Jalid Sehouli, Gabriel Fiol Ruiz, Sara Brucker, Tanja Fehm, Kyeongmi Cheon, Sonali Rawat, Alain Luxembourg, Frederick Wittke
Vaccine 2021;39(20):2800-2809